Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Radiation boost may extend life in early-spread lung cancer

NCT ID NCT06141070

First seen Apr 28, 2026 · Last updated Jun 18, 2026 · Updated 8 times

Summary

This study tests whether adding targeted, high-dose radiation to standard drug therapy (chemotherapy or immunotherapy) helps people with non-small cell lung cancer that has spread to up to 5 spots live longer. About 240 participants will be randomly assigned to receive either standard treatment alone or standard treatment plus radiation to all known cancer spots. The main goal is to see if the combination improves overall survival.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Dept of Oncology

    RECRUITING

    Gothenburg, 41345, Sweden

    Contact Email: •••••@•••••

  • Dept of Oncology

    RECRUITING

    Stockholm, Sweden

    Contact Email: •••••@•••••

  • Dept of pulmonary medicine

    NOT_YET_RECRUITING

    Linköping, Sweden

    Contact Email: •••••@•••••

  • Dept of pulmonary medicine

    NOT_YET_RECRUITING

    Lund, Sweden

    Contact Email: •••••@•••••

  • Dept. of Oncology

    RECRUITING

    Umeå, Sweden

    Contact Email: •••••@•••••

  • Dept. of Oncology

    RECRUITING

    Uppsala, Sweden

    Contact Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.